L-NAME and 7-Nitroindazole Reduces Brain Injuries in Transient Focal Cerebral Ischemia in Rat

Authors

  • A. Vakili Department of Physiology, Shiraz University of Medical Sciences, Shiraz, Iran
  • A.A. Nekooeian Department of Pharmacology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
  • G.A. Dehghani Medicinal & Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract:

Background: The role of nitric oxide (NO) of endothelial or neuronal origins in cerebral ischemia and reperfusion injuries are far from being settled, extending from being important to not having any role at all.  Objective: To investigate the role of NO of endothelial and neuronal origins in ischemia/reperfusion injuries in focal cerebral ischemia, L-NAME, a non selective NO synthase inhibitor (NOS), and 7-nitroindazole (7-NI), a selective neuronal NOS were used. Methods: Transient focal cerebral ischemia was induced in rats by 90 min occlusion of middle cerebral artery, followed by 24 hr reperfusion. Vehicle (saline, DMSO), L-NAME (1 mg/kg) or 7-NI (50 mg/kg) was administered ip at 30 min before or 60 min after the onset of ischemia.  At the end of reperfusion period, neurological deficit score (NDS) test was performed. Then under deep anesthesia the brain removed and prepared for the evaluation of cortical and striatal infarct volumes using Triphenyltetrazolium chloride staining.  Results: Pre-ischemic administration of L-NAME significantly lowered cortical (-66±6%) and striatal (-45±12%) infarct volumes with a concomitant improved NDS (-38±10%).  A significant decrement in cortical (-39±7%) and striatal (-26±5%) infarct volumes occurred during post-ischemic administration of L-NAME without an improvement in NDS. Pre-ischemic administration of 7-NI also significantly reduced cortical (-37±10%) and striatal (-37±13%) infarct volumes, but did not change NDS significantly. Whereas, post-ischemic administrations of 7-NI neither changed cortical and striatal infarct volumes nor changed NDS. Conclusion: Our presumptive conclusion is that, in the rat model of transient focal cerebral ischemia, NO of neuronal origin is involved in ischemic and that of endothelial origin participates in reperfusion injuries.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

l-name and 7-nitroindazole reduces brain injuries in transient focal cerebral ischemia in rat

background: the role of nitric oxide (no) of endothelial or neuronal origins in cerebral ischemia and reperfusion injuries are far from being settled, extending from being important to not having any role at all.    objective: to investigate the role of no of endothelial and neuronal origins in ischemia/reperfusion injuries in focal cerebral ischemia, l-name, a non selective no synthase inhibit...

full text

Pre-Ischemic Treatment of Pentoxifylline Reduces Infarct Volumes in Transient Focal Cerebral Ischemia in the Rat

Background: Pentoxifylline (PTX) is used in human for intermittent claudication and cerebral vascular disorders including cerebrovascular dementia. It also inhibits the synthesis of tumor necrosis factor-α (TNF-α), which is believed to be neurotoxic in animal models of cerebral ischemia. The objective of this study was to examine the role of PTX on ischemia/reperfusion injures in rat model of t...

full text

Quantitative evaluation of Blood Brain Barrier permeability in transient focal cerebral ischemia in the rat

Introduction: Development of brain edema following focal cerebral ischemia exacerbates primary ischemic injury. Blood brain barrier (BBB) opening is an important part of edema named as vasogenic brain edema. In this study, quantitative alterations of BBB permeability is experimentally evaluated using transient focal cerebral ischemia in the rat. Methods: Two groups of male rats (ischemic and sh...

full text

Effect of pentoxifylline on brain edema in a rat model of transient focal cerebral ischemia

Pervious studies have shown that pentoxifylline (PTX) has beneficial effects in reduction of stroke and brain trauma injuries in experimental animals. However, there is very little and controversial information about the effect of PTX on brain edema in cerebral ischemia. Therefore, the aim of this study was to determine the effects of different doses of PTX on brain edema and neurological m...

full text

pre-ischemic treatment of pentoxifylline reduces infarct volumes in transient focal cerebral ischemia in the rat

background: pentoxifylline (ptx) is used in human for intermittent claudication and cerebral vascular disorders including cerebrovascular dementia. it also inhibits the synthesis of tumor necrosis factor-α (tnf-α), which is believed to be neurotoxic in animal models of cerebral ischemia. the objective of this study was to examine the role of ptx on ischemia/reperfusion injures in rat model of t...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 29  issue 3

pages  109- 115

publication date 2015-09-29

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023